| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YLPM1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | ANK1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | NIF3L1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | PDLIM7 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | C3orf20 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | NELL2 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | BET1L | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | KCTD2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | CAPRIN1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | MMADHC | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
